A rapid and physiologically relevant hyperthermia-based induction procedure has been utilized to develop an in vivo model of induced herpes simplex virus (HSV) reactivation in outbred Swiss Webster mice. This procedure was found to efficiently reactivate latent virus from both trigeminal and lumbosacral ganglia.
A rapid and physiologically relevant hyperthermia-based induction procedure has been utilized to develop an in vivo model of induced herpes simplex virus (HSV) reactivation in outbred Swiss Webster mice. This procedure was found to efficiently reactivate latent virus from both trigeminal and lumbosacral ganglia.
Examination of the time between hyperthermia and virus production demonstrated that detectable levels of infectious virus were present in ganglia as soon as 14 h posttreatment, with peak percent recoveries at 24 h. These data indicated that the switch from latent to active viral gene transcription occurred rapidly following treatment. Immunohistochemical staining for HSV type 1 antigens revealed rare antigen-positive ganglionic neurons 24 h postinduction. HSV antigens were not detected in any other cell type, and lateral spread of the infection was not observed. This is the first report of the detection of HSV antigens in vivo following induced reactivation in the intact nervous system and demonstrates that the neuron is the site of infectious virus production. In addition, our data strongly suggest that at least some neurons in which HSV antigens are detected during reactivation do not survive. Because the temporal and spatial characteristics of HSV reactivation have been clearly defined, this model is uniquely suited for the molecular dissection of the reactivation process.
Central to herpes simplex virus (HSV) pathogenesis in humans is the establishment and maintenance of its genome in a latent state. During primary infection at the body surface, the virus is transported through the axonal processes of innervating sensory neurons to the cell body, where it resides in a latent state. Periodic reactivation of this latent virus can result in a lifelong course of recurrent disease (see reference 22 for a review). This aspect of the natural history of HSV remains the fundamental challenge to the treatment and eventual elimination of this human pathogen.
Stimuli such as fever, sunburn, trauma, and other types of stress are commonly associated with the reactivation of latent virus in humans and are thus considered "induction triggers" (22, 29) . However, the molecular mechanisms underlying the induction-reactivation pathway of HSV remain unknown. This is due primarily to the lack of a model system in which the timing of early reactivation events can be accurately predicted. In vivo reactivation models have been developed for a number of species (2, 7, 11, 12, 14, 15, 21, (26) (27) (28) 38) . These models have proven valuable for addressing many aspects of HSV pathogenesis; however, the induction procedures most commonly require several days and reactivation occurs during a subsequent 3 to 7 days. In addition, the animals in which induction procedures have been most effective, namely, rabbits (2, 7, 10, 11, 14, 15) and guinea pigs (28) , experience significant levels of spontaneous reactivation, which complicates the analysis of early molecular events.
Mice are not subject to significant spontaneous reactivation (12, 20, 26) , but in them, virus has been notoriously difficult to reactivate by induction in any reasonable percentage (12, 21, 26 It has been well documented that latency can be established in ganglionic neurons (30) , but the number, type, and fate of reactivating cells is not known. It is assumed that the earliest reactivation events occur in neurons, and it has been suggested that they may survive reactivation through some unknown mechanism (15, 29) . For the first time, HSV antigens were detected during a physiologically relevant reactivation event in vivo. These results offer compelling evidence that the ganglionic neuron is the site of reactivation and infectious virion production. Only 1 to 3 antigen-positive neurons per ganglion were detected, and histologic examination strongly indicated that at least some of these antigenpositive neurons did not survive.
This model is well suited to exploration of viral gene products involved in the establishment, maintenance, and in vivo reactivation of HSV latency. In the accompanying report (24a), we detail our findings utilizing this model to examine the role of the latency-associated transcript transcription unit of HSV-1 in both trigeminal and lumbosacral ganglionic neurons.
MATERIALS AND METHODS
Mice. Male Swiss Webster mice (Charles River), 4 to 5 weeks of age, were used throughout these studies. Animals were housed in American Association for Laboratory Animal Care-approved quarters with unlimited access to food of the Medical Research Council Virology Unit in Glasgow, Scotland, and the derivation and history of this strain have been described previously (34) . HSV-1 KOS(M) was obtained from M. Levine, Ann Arbor, Mich., and has been described previously (32) . Viral stocks were generated by routine propagation in rabbit skin cells (RSC). Infected cells were harvested and sonicated, and the titer of the stock was determined by serial dilution plaque assay on RSC monolayers as previously described (33 (ii) Procedure. The protocol used was adapted from one developed by Germain et al. to induce neural tube defects in mouse embryos (8) . Mice were restrained, and the temperature probe was carefully inserted into the rectum to a depth of 3 cm. A piece of 3-mm latex tubing was slipped over the tail and temperature probe to keep the probe in place. The animal in the restrainer was then slowly lowered into a water bath equilibrated at 43°C. The rate of temperature increase was regulated by raising or lowering the animal in the water. After removal from the water bath, animals were gently blotted with paper toweling and placed in a 34WC dry incubator for 30 min to prevent hypothermia.
Detection of virus reactivated in vivo. (i) Isolation of infectious virus from ganglia. Ganglia were removed aseptically and homogenized in 0.5 ml of media. Homogenates were subsequently frozen and thawed to disrupt the cells and centrifuged briefly to remove cell debris, and the supernatants were layered onto newly confluent RSC monolayers and incubated for 45 min at 37°C in 5% CO2. Monolayers were then rinsed and, after the addition of fresh media, were incubated at 37°C in 5% CO2 and observed daily for cytopathic effect. The sensitivity of this assay procedure was estimated by reconstitution experiments in which ganglia were homogenized with 10-fold dilutions of viral stocks of known titers. The amount of input virus was compared with the number of PFU recovered after homogenization and plating on RSC monolayers.
(ii) In situ detection of viral antigens. Anesthetized animals were perfused with 4% paraformaldehyde, and ganglia were removed and postfixed for 1 h. Fixed tissues were dehydrated in a graded series of ethanols, embedded in paraffin, and sectioned at 5 p,m. Localization of HSV antigens was performed by using a three-step biotin-avidin peroxidase system as previously described (16) . Rabbit anti-HSV (type I) (Accurate Scientific) absorbed with normal mouse liver acetone powder was used at a dilution of 1:1,500. Specificity of this reagent was confirmed by using a series of known HSV-positive and -negative tissue specimens. Biotinylated goat anti-rabbit immunoglobulin G (Vector Laboratories, Burlingame, Calif.) absorbed with normal mouse serum was used at a dilution of 1:150. Details of the immunohistochemical procedure, including the avidin-peroxidase conjugate and substrate reaction, have been described previously (24) . Negative controls consisting of serial or step sections incubated with a 1:1,000 dilution of normal rabbit serum in place of the anti-HSV antibody were included in each experiment. Detection of heat shock proteins. Extract preparation and
Western blot (immunoblot) analysis. Extracts of trigeminal and lumbosacral ganglia were prepared by homogenization in phosphate-buffered saline (PBS) containing 0.5% Nonidet P-40. Nuclei and insoluble material were removed by centrifugation, and extracts were boiled in sodium dodecyl sulfate (SDS), loaded onto 7% polyacrylamide gels, and electrophoresed according to the procedure of Laemmli (18) .
The electrophoresed proteins were transferred to nitrocellulose as described previously (35) . The uniformity of transfer was evaluated by staining the nitrocellulose with Ponceau S, which was subsequently removed by washing in PBS. Western blot analysis of the transferred proteins was carried out with a 10-well blotting chamber (Hoefer Scientific) by using a three-step biotin-avidin-peroxidase system (16) . The primary antibody C92F3A-5 (SPA-801) (StressGen, Victoria, British Columbia, Canada) was used at a 1:1,000 dilution. The secondary antibody, biotinylated horse anti-mouse immunoglobulin G (Vector Laboratories), was diluted 1:500; the peroxidase conjugate was diluted 1:200; and a 0.25% solution of 4-chloro-1-naphthol containing 0.05% H202 was used as the chromogenic substrate.
RESULTS
Hyperthermia. Our selection of hyperthermia or heat stress as a possible induction trigger was based on the strong correlation between fever and HSV reactivation in humans (3, 4, 22) . Although this association is merely correlative, cellular responses to other known triggers of HSV reactivation, including UV irradiation, trauma, and certain types of hormonal stress, are related to the basic cellular stress response (for a review, see reference 36).
The procedure developed is based on inducing hyperthermia by immersion in warm water as described previously (8) . This protocol has the advantage of being brief, reproducible, and well tolerated by the animals. The rate of rise in core body temperature could be controlled by the depth of immersion of the animal. This rate was maintained at approximately 1°C per minute. The core body temperature reached 43°C at 7 min and plateaued at 43°C for just a little more than 3 min. After this procedure, the core body temperature returned to normal within 10 min. It tial to dry the animals and place them in a warm (34°C) incubator for about 30 min to prevent hypothermia.
Heat shock protein synthesis. In order to determine whether this procedure induced a stress response in relevant target tissues, heat shock protein 70 (HSP70) synthesis in trigeminal and lumbosacral ganglia was examined. Tissues from uninfected mice were harvested pretreatment and 12 h posttreatment. Ganglionic protein extracts were produced as described above, and 10 ,ug per lane was electrophoresed by SDS-polyacrylamide gel electrophoresis (PAGE) and examined by Western blot analysis with monoclonal antibody C92F3A-5. This antibody has been characterized extensively and shown to be specific for the inducible form of HSP70 (37) . This protein is not expressed at detectable levels under normal growth conditions but is expressed at high levels as part of the stress response (37) . NIH 3T3 cell protein extracts from cells maintained at 37°C or heat shocked for 30 min at 44°C and maintained at 37°C for an additional 12 h served as negative and positive controls. As shown in Fig. 1 scarification) were sacrificed at 14 h (n = 10), 24 h (n = 10), and 48 h (n = 10) after treatment and trigeminal ganglia were assayed for infectious virus. Infectious virus was recovered as soon as 14 h posttreatment, with peak percent recovery at 24 h (60%). By 48 h postinduction, the number of animals positive for infectious virus dropped significantly (Fig. 2) (33) . If this is also the case for neurons in vivo, this assay would be sensitive enough to detect the progeny virus from a single reactivating cell. The fact that antigen-positive cells are quite rare in reactivating ganglia (see below) suggests that this is the case.
Whether the difference seen in reactivation frequencies between these strains reflects a difference in the induction of reactivation, the inability of KOS(M) to replicate to detectable levels following reactivation, or the inefficient establishment of latency by KOS(M), was not determined. However, others have reported increased establishment efficiencies for strain KOS in mice (25) , suggesting that this strain may indeed contain a defect in a function required for induced reactivation.
Reactivation occurs in neurons. The type of cell in which reactivation occurs in vivo has not been unambiguously identified (15, 29) . The close temporal link between induction and reactivation in this model allowed the direct examination of this problem. Immunohistochemical staining demonstrated the restricted localization of viral antigens in large ganglionic neurons 24 h postinduction. Figure 4A was low (1 to 3 neurons positive per reactivating ganglion). HSV antigens were not detected in any other cell type within the ganglion, and lateral spread of the virus was not seen. These data are the first definitive demonstration of active viral protein production in intact ganglionic neurons during reactivation. Coupled with the fact that infectious virus can be isolated at this time, these findings offer compelling evidence that infectious virion production occurred in neurons.
The reactivating neurons displayed degenerative changes in the nucleus and cytoplasm. When viewed at higher magnification (Fig. 4B) , many large vacuoles (arrows) can be seen in the cytoplasm of the reactivating neuron shown in Fig. 4A . These degenerative changes are strong evidence that this neuron did not survive.
A mononuclear cell infiltrate localized to regions of reactivating neurons was observed in ganglia at 24 h posttreatment (Fig. 4C, counterstained (5, 30) , and only recently has conclusive proof of latency in ganglionic neu-rons been obtained (31) . Despite the availability of animal models of induced reactivation of HSV, this event has not been previously observed in the intact nervous system, and many basic questions remain unresolved. Definitive evidence of the type, number, and fate of the cells in which reactivation occurs is lacking (29) , and nothing is known about the precise molecular events which lead to the establishment of and reactivation from latency (1, 22, 29) . De These kinetics differ. from those reported by others in which the peak virus production in trigeminal ganglia following reactivation in vivo (4 of 14 trigeminal ganglia positive of those tested) was found to be at 3 days postinduction. In that study, reactivation was induced by a 2-day administration of cyclophosphamide and dexamethasone followed by UV irradiation of the eye in a mouse model (26 (17, 36) . This heat shock response has been examined at length and includes a complex regulatory cascade resulting in the rapid accumulation of a specific set of proteins and a decrease in others. This extremely rapid alteration in the cellular protein profile is the result of regulatory events at many levels, including transcription (17, 36) . Indeed, the cis elements involved in this transcriptional regulatory system comprise the most highly conserved genetic system known. We have shown that the hyperthermia treatment induces heat shock proteins in trigeminal and lumbosacral ganglia. However, demonstrating that the heat shock response is induced does not indicate a causal connection to reactivation. Indeed, HSV infection of cells cultured at elevated temperatures has been found to repress viral replication, and this finding is the basis for several in vitro models of latency (13, 23) . Certainly the cascade of events occurring at the organismal level which result in HSV reactivation are bound to be complex. The hyperthermia reactivation model is a system with which to address the molecular mechanisms underlying reactivation and to identify viral genes which contribute to the phenotypic variation in this function observed among different viral strains.
